Benjamin Chien, Ph.d.
Chairman, President and CEO of QPS Holdings, LLC
biotechnology
QPS
Austria
Biography
Dr. Chien began his pharmaceutical career at DuPont Merck Pharmaceutical Co. in the Drug Metabolism and Pharmacokinetics Section where he built the LC-MS/MS group. While at DuPont Merck, he received the Summit Award for his contribution to the development of Sustiva®, an anti-viral drug approved by the FDA for the treatment of HIV. In addition, Dr. Chien is the co-inventor of a novel Ion Trap/Time-of-Flight Mass Spectrometer. Dr. Chien obtained his Ph.D. in analytical chemistry (mass spectrometry) from the University of Michigan at Ann Arbor.
Research Interest
mass spectrometry
